Optical imaging is a valuable tool for investigating alterations in membrane turnover and vesicle trafficking. Established techniques can easily be adapted to study the mechanisms of synaptic dysfunction in models of neuropsychiatric disorders and neurodegenerative diseases, such as drug addiction, Parkinsonism, and Huntington's disease. Fluorescent endocytic tracers, including FM1-43, have been used to optically monitor synaptic vesicle fusion and measure synaptic function in various preparations, including chromaffin cells, dissociated cell cultures, and brain slices. In this chapter, we describe a technique that provides a direct measure of pathway-specific exocytosis from glutamatergic corticostriatal terminals. Neurotransmitter release and reuptake from recycling synaptic terminals is tightly regulated and alterations in vesicular turnover or in the availability of neuromodulators that act presynaptically can be features of neurodegenerative conditions (1). Optical tracers that label individual axon terminals in an activity-dependent manner have become useful tools in neurobiology and are responsible for improving our understanding about membrane trafficking and synaptic activity. When combined with standard electrophysiological techniques, optical recordings enable synapse modeling by showing how neuromodulators select subsets of presynaptic terminals, leading to changes in postsynaptic activation.Perhaps the first optical tracer to monitor neurotransmitter release used horseradish peroxidase, which in the presence of appropriate substrates can produce a colored or electron-dense